Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall augmentation in MDD
NCT02058693Phase 4Completed
- Sponsor
- Rush University Medical Center
- Start
- Dec 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextroamphetamine + amphetamine in major depressive disorder (MDD), sponsored by Rush University Medical Center. Started Dec 2010; status: completed.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02058693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058693.